Clinical Trial Update: A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe Hypertriglyceridemia [Phase 2]

View source ↗

Summary

Phase 2 study of olezarsen (formerly AKCEA-APOCIII-LRx) in adults with hypertriglyceridemia and atherosclerotic cardiovascular disease or severe hypertriglyceri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Hypertriglyceridemia

Drugs mentioned

• Olezarsen (olezarsen)

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Hypertriglyceridemia, Atherosclerotic Cardiovascular Disease | Phase 2 | Status: COMPLETED | Results posted: 2026-04-23